Found 133 hits of affinity data for UniProtKB/TrEMBL: Q45894Target (Institution) | Ligand | Target Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | pH | Temp °C |
Botulinum Neurotoxin Type A
Clostridium botulinum | Cinnamic hydroxamate deriv., 18
 ((2E)-3-(2,4-dichlorophenyl)-N-hydroxyprop-2-enamid...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| B.MOAD CSLS MMDB PC cid PC sid PDB
| B.MOAD PDB PubMed
| n/a | n/a | 410.0 | n/a | n/a | 7.4 | 22.5 |
The Scripps Research Institute
|
Org Lett. 8: 1729-32 (2006)
 |
Botulinum Neurotoxin Type A
Clostridium botulinum | hydroxamate derivative, 5g
 ((2E)-3-[4-chloro-2-(trifluoromethyl)phenyl]-N-hydr...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| PC cid PC sid
| PubMed
| n/a | n/a | 600.0 | n/a | n/a | 7.4 | 23 |
The Scripps Research Institute
|
Bioorg Med Chem Lett. 17: 6463-6 (2007)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | hydroxamate derivative, 5b
 ((2E)-3-(2-bromo-4-chlorophenyl)-N-hydroxyprop-2-en...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| PC cid PC sid
| PubMed
| n/a | n/a | 700.0 | n/a | n/a | 7.4 | 23 |
The Scripps Research Institute
|
Bioorg Med Chem Lett. 17: 6463-6 (2007)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | hydroxamate derivative, 5f
 ((2E)-3-(4-chloro-2-methylphenyl)-N-hydroxyprop-2-e...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| PC cid PC sid
| PubMed
| n/a | n/a | 800.0 | n/a | n/a | 7.4 | 23 |
The Scripps Research Institute
|
Bioorg Med Chem Lett. 17: 6463-6 (2007)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | Cinnamic hydroxamate deriv., 18
 ((2E)-3-(2,4-dichlorophenyl)-N-hydroxyprop-2-enamid...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| B.MOAD CSLS MMDB PC cid PC sid PDB
| B.MOAD PDB PubMed
| n/a | n/a | 900.0 | n/a | n/a | 7.4 | 23 |
The Scripps Research Institute
|
Bioorg Med Chem Lett. 17: 6463-6 (2007)
 |
Botulinum Neurotoxin Type A
Clostridium botulinum | hydroxamate derivative, 5i
 ((2E)-3-(4-chloro-2-nitrophenyl)-N-hydroxyprop-2-en...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| PC cid PC sid
| PubMed
| n/a | n/a | 2000.0 | n/a | n/a | 7.4 | 23 |
The Scripps Research Institute
|
Bioorg Med Chem Lett. 17: 6463-6 (2007)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | Cinnamic hydroxamate deriv., 18
 ((2E)-3-(2,4-dichlorophenyl)-N-hydroxyprop-2-enamid...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| B.MOAD CSLS MMDB PC cid PC sid PDB
| B.MOAD PDB PubMed
| n/a | n/a | 2400.0 | n/a | n/a | 7.4 | 22 |
Absolute Science, Inc.
|
Bioorg Med Chem. 17: 3072-9 (2009)
 |
Botulinum Neurotoxin Type A
Clostridium botulinum | 2-mercaptoacetamide, 12l
 (N-[3-(4-nitrophenyl)-1H-pyrazol-5-yl]-2-sulfanylac...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| PC cid PC sid
| PubMed
| n/a | n/a | 2900.0 | n/a | n/a | 7.4 | 22 |
Absolute Science, Inc.
|
Bioorg Med Chem. 17: 3072-9 (2009)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | Cinnamic hydroxamate deriv., 19
 (3-(2,4-dichlorophenyl)-N-hydroxypropanamide) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| n/a | n/a | 3100.0 | n/a | n/a | 7.4 | 22.5 |
The Scripps Research Institute
|
Org Lett. 8: 1729-32 (2006)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | 4-amino-7-chloroquinoline (ACQ)-based compound, 4
 (N-{3-[bis({3-[(7-chloroquinolin-4-yl)amino]propyl}...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| n/a | n/a | 3200.0 | n/a | n/a | 7.3 | 22 |
National Cancer Institute at Frederick
|
J Med Chem. 50: 2127-36 (2007)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | hydroxamate derivative, 5a
 ((2E)-3-(4-chloro-2-fluorophenyl)-N-hydroxyprop-2-e...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| PC cid PC sid
| PubMed
| n/a | n/a | 4400.0 | n/a | n/a | 7.4 | 23 |
The Scripps Research Institute
|
Bioorg Med Chem Lett. 17: 6463-6 (2007)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | 2-mercaptoacetamide, 12a
 (N-[3-(4-chlorophenyl)-1H-pyrazol-5-yl]-2-sulfanyla...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| PC cid PC sid
| PubMed
| n/a | n/a | 4800.0 | n/a | n/a | 7.4 | 22 |
Absolute Science, Inc.
|
Bioorg Med Chem. 17: 3072-9 (2009)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | hydroxamate derivative, 5d
 ((2E)-3-[4-chloro-2-(methylsulfanyl)phenyl]-N-hydro...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| PC cid PC sid
| PubMed
| n/a | n/a | 5100.0 | n/a | n/a | 7.4 | 23 |
The Scripps Research Institute
|
Bioorg Med Chem Lett. 17: 6463-6 (2007)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | rhodanine derivative, 35
 (2-[(5Z)-5-{[1,3-bis(4-bromophenyl)-1H-pyrazol-4-yl...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| PC cid PC sid
| PubMed
| n/a | n/a | 5450.0 | n/a | n/a | 8 | 25 |
Burnham Institute for Medical Research
|
Chem Biol Drug Des. 71: 131-9 (2008)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | 2-mercaptoacetamide, 12g
 (N-[3-(3-chlorophenyl)-1H-pyrazol-5-yl]-2-sulfanyla...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| PC cid PC sid
| PubMed
| n/a | n/a | 5600.0 | n/a | n/a | 7.4 | 22 |
Absolute Science, Inc.
|
Bioorg Med Chem. 17: 3072-9 (2009)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | 2-mercaptoacetamide, 12i
 (N-[3-(4-bromophenyl)-1H-pyrazol-5-yl]-2-sulfanylac...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| PC cid PC sid
| PubMed
| n/a | n/a | 6600.0 | n/a | n/a | 7.4 | 22 |
Absolute Science, Inc.
|
Bioorg Med Chem. 17: 3072-9 (2009)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | 4-amino-7-chloroquinoline (ACQ)-based compound, 3
 (JMC514388 Compound 8 | methyl (4R)-4-[(2S,5R,7S,9R...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| PC cid PC sid
| PubMed
| n/a | n/a | 7000.0 | n/a | n/a | 7.3 | 37 |
UniVersity of Belgrade
|
J Med Chem. 51: 4388-91 (2008)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | 4-amino-7-chloroquinoline (ACQ)-based compound, 3
 (JMC514388 Compound 8 | methyl (4R)-4-[(2S,5R,7S,9R...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| PC cid PC sid
| PubMed
| n/a | n/a | 7000.0 | n/a | n/a | 7.3 | 22 |
National Cancer Institute at Frederick
|
J Med Chem. 50: 2127-36 (2007)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | 2-mercaptoacetamide, 12f
 (2-sulfanyl-N-{3-[2-(trifluoromethyl)phenyl]-1H-pyr...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| PC cid PC sid
| PubMed
| n/a | n/a | 7200.0 | n/a | n/a | 7.4 | 22 |
Absolute Science, Inc.
|
Bioorg Med Chem. 17: 3072-9 (2009)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | HD4-A2B7
 (1-{[({[2-(4-methoxyphenyl)ethyl]carbamoyl}methyl)(...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| PC cid PC sid
| PubMed
| n/a | n/a | 7600.0 | n/a | n/a | 7.4 | 23 |
The Scripps Research Institute
|
Proc Natl Acad Sci U S A. 104: 2602-7 (2007)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | rhodanine derivative, 34
 (2-[(5Z)-5-{[1,3-bis(4-chlorophenyl)-1H-pyrazol-4-y...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| PC cid PC sid
| PubMed
| n/a | n/a | 8180.0 | n/a | n/a | 8 | 25 |
Burnham Institute for Medical Research
|
Chem Biol Drug Des. 71: 131-9 (2008)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | hydroxamate derivative, 5c
 ((2E)-3-(4-chloro-2-methoxyphenyl)-N-hydroxyprop-2-...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| PC cid PC sid
| PubMed
| n/a | n/a | 9000.0 | n/a | n/a | 7.4 | 23 |
The Scripps Research Institute
|
Bioorg Med Chem Lett. 17: 6463-6 (2007)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | rhodanine derivative, 9
 (2-[(5Z)-5-{[5-(3-nitrophenyl)furan-2-yl]methyliden...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| n/a | n/a | 9720.0 | n/a | n/a | 8 | 25 |
Burnham Institute for Medical Research
|
Chem Biol Drug Des. 71: 131-9 (2008)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | 4-amino-7-chloroquinoline (ACQ)-based compound, 1
 ((2S,5R,7S,9R,14R,15R,16S)-14-[(1R)-4-({2-[(7-chlor...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| PC cid PC sid
| PubMed
| n/a | n/a | 10000.0 | n/a | n/a | 7.3 | 22 |
National Cancer Institute at Frederick
|
J Med Chem. 50: 2127-36 (2007)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | 2-mercaptoacetamide, 12d
 (2-sulfanyl-N-{3-[4-(trifluoromethyl)phenyl]-1H-pyr...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| PC cid PC sid
| PubMed
| n/a | n/a | 10000.0 | n/a | n/a | 7.4 | 22 |
Absolute Science, Inc.
|
Bioorg Med Chem. 17: 3072-9 (2009)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | 4-amino-7-chloroquinoline (ACQ)-based compound, 1
 ((2S,5R,7S,9R,14R,15R,16S)-14-[(1R)-4-({2-[(7-chlor...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| PC cid PC sid
| PubMed
| n/a | n/a | 10000.0 | n/a | n/a | 7.3 | 37 |
UniVersity of Belgrade
|
J Med Chem. 51: 4388-91 (2008)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | rhodanine derivative, 11
 (2-[(5Z)-5-{[5-(3,4-dichlorophenyl)furan-2-yl]methy...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| n/a | n/a | 11100.0 | n/a | n/a | 8 | 25 |
Burnham Institute for Medical Research
|
Chem Biol Drug Des. 71: 131-9 (2008)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | rhodanine derivative, 4
 (2-[(5Z)-5-{[5-(2-chloro-4-nitrophenyl)furan-2-yl]m...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| n/a | n/a | 11800.0 | n/a | n/a | 8 | 25 |
Burnham Institute for Medical Research
|
Chem Biol Drug Des. 71: 131-9 (2008)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | 4-Aminoquinoline, 17
 ([2-(adamantan-1-yl)ethyl]({2-[(7-chloroquinolin-4-...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| PC cid PC sid
| PubMed
| n/a | n/a | 11810.0 | n/a | n/a | 7.3 | 37 |
UniVersity of Belgrade
|
J Med Chem. 51: 4388-91 (2008)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | hydroxamate derivative, 5k
 ((2E)-3-(4-chloro-2-cyanophenyl)-N-hydroxyprop-2-en...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| PC cid PC sid
| PubMed
| n/a | n/a | 12000.0 | n/a | n/a | 7.4 | 23 |
The Scripps Research Institute
|
Bioorg Med Chem Lett. 17: 6463-6 (2007)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | NA-A1B2C10
 (6-ethyl-1-[(4-methylphenyl)methyl]-4-[(2E)-3-pheny...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| n/a | n/a | 12500.0 | n/a | n/a | 7.4 | 23 |
The Scripps Research Institute
|
Proc Natl Acad Sci U S A. 104: 2602-7 (2007)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | hydroxamate derivative, 5h
 ((2E)-3-(4-chloro-2-hydroxyphenyl)-N-hydroxyprop-2-...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| PC cid PC sid
| PubMed
| n/a | n/a | 13000.0 | n/a | n/a | 7.4 | 23 |
The Scripps Research Institute
|
Bioorg Med Chem Lett. 17: 6463-6 (2007)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | 2-mercaptoacetamide, 12c
 (2-sulfanyl-N-{3-[3-(trifluoromethyl)phenyl]-1H-pyr...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| PC cid PC sid
| PubMed
| n/a | n/a | 13000.0 | n/a | n/a | 7.4 | 22 |
Absolute Science, Inc.
|
Bioorg Med Chem. 17: 3072-9 (2009)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | 2-mercaptoacetamide, 12h
 (N-[3-(4-fluorophenyl)-1H-pyrazol-5-yl]-2-sulfanyla...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| PC cid PC sid
| PubMed
| n/a | n/a | 13500.0 | n/a | n/a | 7.4 | 22 |
Absolute Science, Inc.
|
Bioorg Med Chem. 17: 3072-9 (2009)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | HD4-A3B5
 (1-({[({[3-fluoro-5-(trifluoromethyl)phenyl]methyl}...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| PC cid PC sid
| PubMed
| n/a | n/a | 14300.0 | n/a | n/a | 7.4 | 23 |
The Scripps Research Institute
|
Proc Natl Acad Sci U S A. 104: 2602-7 (2007)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | 2-mercaptoacetamide, 12e
 (N-(3-phenyl-1H-pyrazol-5-yl)-2-sulfanylacetamide) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| PC cid PC sid
| PubMed
| n/a | n/a | 14500.0 | n/a | n/a | 7.4 | 22 |
Absolute Science, Inc.
|
Bioorg Med Chem. 17: 3072-9 (2009)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | 4-chlorocinnamic hydroxamate, 1
 ((2E)-3-(4-chlorophenyl)-N-hydroxyprop-2-enamide) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| B.MOAD CSLS MMDB PC cid PC sid PDB
| B.MOAD PDB PubMed
| n/a | n/a | 15000.0 | n/a | n/a | 7.4 | 23 |
The Scripps Research Institute
|
Bioorg Med Chem Lett. 17: 6463-6 (2007)
 |
Botulinum Neurotoxin Type A
Clostridium botulinum | 4-amino-7-chloroquinoline (ACQ)-based compound, 2
 (JMC514388 Compound 7 | methyl (4R)-4-[(2S,5S,7S,9R...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| PC cid PC sid
| PubMed
| n/a | n/a | 17000.0 | n/a | n/a | 7.3 | 22 |
National Cancer Institute at Frederick
|
J Med Chem. 50: 2127-36 (2007)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | hydroxamate derivative, 5j
 ((2E)-3-(4-chloro-2-methanesulfonylphenyl)-N-hydrox...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| PC cid PC sid
| PubMed
| n/a | n/a | 17000.0 | n/a | n/a | 7.4 | 23 |
The Scripps Research Institute
|
Bioorg Med Chem Lett. 17: 6463-6 (2007)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | 4-amino-7-chloroquinoline (ACQ)-based compound, 2
 (JMC514388 Compound 7 | methyl (4R)-4-[(2S,5S,7S,9R...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| PC cid PC sid
| PubMed
| n/a | n/a | 17000.0 | n/a | n/a | 7.3 | 37 |
UniVersity of Belgrade
|
J Med Chem. 51: 4388-91 (2008)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | 4-Aminoquinoline, 20
 ((adamantan-1-ylmethyl)({2-[(7-chloroquinolin-4-yl)...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| PC cid PC sid
| PubMed
| n/a | n/a | 18920.0 | n/a | n/a | 7.3 | 37 |
UniVersity of Belgrade
|
J Med Chem. 51: 4388-91 (2008)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | HD4-A4B2
 (1-{[({[2-(3-methoxyphenyl)ethyl]carbamoyl}methyl)[...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| PC cid PC sid
| PubMed
| n/a | n/a | 19100.0 | n/a | n/a | 7.4 | 23 |
The Scripps Research Institute
|
Proc Natl Acad Sci U S A. 104: 2602-7 (2007)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | rhodanine derivative, 10
 (2-[(5Z)-5-{[5-(3-chlorophenyl)furan-2-yl]methylide...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| n/a | n/a | 19900.0 | n/a | n/a | 8 | 25 |
Burnham Institute for Medical Research
|
Chem Biol Drug Des. 71: 131-9 (2008)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | rhodanine derivative, 43
 (2-[(5Z)-4-oxo-5-({1-phenyl-3-[4-(piperidine-1-sulf...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| n/a | n/a | 20100.0 | n/a | n/a | 8 | 25 |
Burnham Institute for Medical Research
|
Chem Biol Drug Des. 71: 131-9 (2008)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | hydroxamate derivative, 3a
 (6-chloro-N-hydroxynaphthalene-2-carboxamide) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| PC cid PC sid
| PubMed
| n/a | n/a | 21000.0 | n/a | n/a | 7.4 | 23 |
The Scripps Research Institute
|
Bioorg Med Chem Lett. 17: 6463-6 (2007)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | 2-mercaptoacetamide, 12j
 (N-[3-(4-methylphenyl)-1H-pyrazol-5-yl]-2-sulfanyla...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| PC cid PC sid
| PubMed
| n/a | n/a | 21000.0 | n/a | n/a | 7.4 | 22 |
Absolute Science, Inc.
|
Bioorg Med Chem. 17: 3072-9 (2009)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | hydroxamate derivative, 5e
 ((2E)-3-(2-amino-4-chlorophenyl)-N-hydroxyprop-2-en...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| PC cid PC sid
| PubMed
| n/a | n/a | 25000.0 | n/a | n/a | 7.4 | 23 |
The Scripps Research Institute
|
Bioorg Med Chem Lett. 17: 6463-6 (2007)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | 2-mercaptoacetamide, 12b
 (N-[3-(2-chlorophenyl)-1H-pyrazol-5-yl]-2-sulfanyla...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| PC cid PC sid
| PubMed
| n/a | n/a | 26000.0 | n/a | n/a | 7.4 | 22 |
Absolute Science, Inc.
|
Bioorg Med Chem. 17: 3072-9 (2009)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | rhodanine derivative, 41
 (2-[(5Z)-5-{[3-(4-chlorophenyl)-1-phenyl-1H-pyrazol...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| CSLS PC cid PC sid
| PubMed
| n/a | n/a | 26400.0 | n/a | n/a | 8 | 25 |
Burnham Institute for Medical Research
|
Chem Biol Drug Des. 71: 131-9 (2008)
|
Botulinum Neurotoxin Type A
Clostridium botulinum | 4-Aminoquinoline, 21
 ((adamantan-1-ylmethyl)({3-[(7-chloroquinolin-4-yl)...) | B.MOAD GoogleScholar KEGG MMDB PDB UniProtKB/SwissProt UniProtKB/TrEMBL
| PC cid PC sid
| PubMed
| n/a | n/a | 31980.0 | n/a | n/a | 7.3 | 37 |
UniVersity of Belgrade
|
J Med Chem. 51: 4388-91 (2008)
|